Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Swerdlow

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Vaccines|March 26, 2022
COVID-19 Vaccine Effectiveness: A Review of the First 6 Months of COVID-19 Vaccine Availability (1 January-30 June 2021)Sarah M Hatcher, Stacy M Endres-Dighe, Frederick J Angulo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2018
Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative DesignJohn M McLaughlin, Qin Jiang, Raul E Isturiz, et al.
Annals of Epidemiology|July 9, 2011
Racial and ethnic disparities in hospitalizations and deaths associated with 2009 pandemic Influenza A (H1N1) virus infections in the United StatesDeborah L Dee, Diana M Bensyl, Jacqueline Gindler, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|December 26, 2006
Serologic evidence for exposure to Rickettsia rickettsii in eastern Arizona and recent emergence of Rocky Mountain spotted fever in this regionLinda J Demma, Marc Traeger, Dianna Blau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 24, 2011
Serial intervals and the temporal distribution of secondary infections within households of 2009 pandemic influenza A (H1N1): implications for influenza control recommendationsChristl A Donnelly, Lyn Finelli, Simon Cauchemez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 24, 2011
Transmission of pandemic (H1N1) 2009 influenza to healthcare personnel in the United StatesMatthew E Wise, Marie De Perio, John Halpin, et al.
Lancet (London, England)|May 8, 2021
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance dataEric J Haas, Frederick J Angulo, John M McLaughlin, et al.
Public Health Reports (Washington, D.C. : 1974)|September 9, 2015
CDC's Early Response to a Novel Viral Disease, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), September 2012-May 2014Holly Ann Williams, Richard L Dunville, Susan I Gerber, et al.
Emerging Infectious Diseases|October 25, 2002
Bioterrorism-related anthrax surveillance, Connecticut, September-December, 2001Alcia A Williams, Umesh D Parashar, Adrian Stoica, et al.
Emerging Infectious Diseases|July 24, 2009
Cluster of sylvatic epidemic typhus cases associated with flying squirrels, 2004-2006Alice S Chapman, David L Swerdlow, Virginia M Dato, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Vaccines|March 26, 2022
COVID-19 Vaccine Effectiveness: A Review of the First 6 Months of COVID-19 Vaccine Availability (1 January-30 June 2021)Sarah M Hatcher, Stacy M Endres-Dighe, Frederick J Angulo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2018
Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative DesignJohn M McLaughlin, Qin Jiang, Raul E Isturiz, et al.
Annals of Epidemiology|July 9, 2011
Racial and ethnic disparities in hospitalizations and deaths associated with 2009 pandemic Influenza A (H1N1) virus infections in the United StatesDeborah L Dee, Diana M Bensyl, Jacqueline Gindler, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|December 26, 2006
Serologic evidence for exposure to Rickettsia rickettsii in eastern Arizona and recent emergence of Rocky Mountain spotted fever in this regionLinda J Demma, Marc Traeger, Dianna Blau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 24, 2011
Serial intervals and the temporal distribution of secondary infections within households of 2009 pandemic influenza A (H1N1): implications for influenza control recommendationsChristl A Donnelly, Lyn Finelli, Simon Cauchemez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 24, 2011
Transmission of pandemic (H1N1) 2009 influenza to healthcare personnel in the United StatesMatthew E Wise, Marie De Perio, John Halpin, et al.
Lancet (London, England)|May 8, 2021
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance dataEric J Haas, Frederick J Angulo, John M McLaughlin, et al.
Public Health Reports (Washington, D.C. : 1974)|September 9, 2015
CDC's Early Response to a Novel Viral Disease, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), September 2012-May 2014Holly Ann Williams, Richard L Dunville, Susan I Gerber, et al.
Emerging Infectious Diseases|October 25, 2002
Bioterrorism-related anthrax surveillance, Connecticut, September-December, 2001Alcia A Williams, Umesh D Parashar, Adrian Stoica, et al.
Emerging Infectious Diseases|July 24, 2009
Cluster of sylvatic epidemic typhus cases associated with flying squirrels, 2004-2006Alice S Chapman, David L Swerdlow, Virginia M Dato, et al.
Pageof 13